1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Glaucoma Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Glaucoma Surgery Devices Market, United States
3.1 Glaucoma Surgery Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Glaucoma Drainage Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Glaucoma Drainage Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033
3.4 Glaucoma Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Glaucoma Surgery Devices Market
4.1 Glaukos Corp
4.1.1 Company Overview
4.2 Allergan Aesthetics
4.2.1 Company Overview
4.3 Alcon Inc
4.3.1 Company Overview
4.4 New World Medical, Incorporated
4.4.1 Company Overview
4.5 Johnson & Johnson Vision Care Inc
4.5.1 Company Overview
5 Glaucoma Surgery Devices Market Pipeline Products6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 Iridex Files Prospectus for Public Offering of Shares
6.1.2 ViaLase Raises USD7.02 Million in Equity Offering
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jun 14, 2024: Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
7.2 Financial Announcements
7.2.1 Oct 30, 2024: STAAR Surgical Announces Q3 2024 Results
7.2.2 Oct 23, 2024: STAAR Surgical to Report Third Quarter Results on October 30, 2024
7.2.3 Oct 09, 2024: Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
7.3 Government and Public Interest
7.3.1 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences
7.4 Other Significant Developments
7.4.1 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
7.5 Product News
7.5.1 Nov 20, 2024: Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
Table 4: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033
Table 5: Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033
Table 6: Glaucoma Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 7: Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 8: Glaucoma Surgery Devices Market Pipeline Products
Table 9: Iridex Files Prospectus for Public Offering of Shares
Table 10: ViaLase Raises USD7.02 Million in Equity Offering
Table 11: Total Number of Primary Research Participants, Ophthalmic Devices Market, by Country
List of Figures
Figure 1: Glaucoma Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Glaucoma Drainage Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033
Figure 4: Glaucoma Drainage Devices Market, United States, Volume (Units), 2018-2033
Figure 5: Glaucoma Surgery Devices Market, United States, Company Share (%) 2023